Paradigm Therapeutics

SC - Mount PleasantBiotechnologySponsors Visas

Focus: Paradigm Therapeutics is a biotechnology company headquartered in Mount Pleasant, SC, focused on topical therapies in oncology and infectious diseases with a diverse pipeline spanning dermatology, orthopedics, and spinal indications.

Oncology Infectious Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Paradigm Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Paradigm Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

3 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Decompression

Intermittent Neurogenic Claudication (INC) as a Result of Spinal Stenosis

N/A

Clinical Trials (1)

NCT01727752A Randomized Controlled Trial Comparing Surgical Decompression With an Interlaminar Implant in Patients With Intermittent Neurogenic Claudication Caused by Lumbar Stenosis

N/A

Help build intelligence for Paradigm Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Phase 3 program in SD-101 Dermal Cream for Epidermolysis Bullosa represents near-term regulatory catalyst with commercial potential in rare disease
Diversified pipeline across oncology, infectious diseases, orthopedics, and spinal conditions provides multiple therapeutic area learning opportunities
Topical therapy specialty positions company in high-margin, patient-friendly drug delivery space with lower manufacturing complexity

Watch Out For

Zero open job postings indicate company is not actively hiring, suggesting limited near-term career entry points or restructuring phase
Missing data on funding, employee count, and financials raises questions about company stability, burn rate, and long-term viability

Generated by Claude from Paradigm Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

coflex® Interlaminar Technology

Spinal Stenosis

N/A

Clinical Trials (1)

NCT03041896Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion

N/A

Dynamic Stabilization System

Spondylolisthesis

N/A

Clinical Trials (1)

NCT01461005A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)

N/A

Decompression

Spinal Stenosis

N/A

Clinical Trials (1)

NCT00534235Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis

N/A

blood and tissue samples

Muscle Invasive Bladder Urothelial Carcinoma

N/A

Clinical Trials (1)

NCT06605404Pan-tumor MRD Study

N/A

Pentosan Polysulphate Sodium

Osteoarthritis, Knee

N/A

Clinical Trials (1)

NCT04814719Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain

N/A

Saliva collection

Covid19

N/A

Clinical Trials (1)

NCT04567953COVID-19 Tests With Saliva Specimens

N/A

Implantation of coflex™ after surgical decompression

Spinal Stenosis

N/A

Clinical Trials (1)

NCT01316211Clinical Trial Comparing Decompression With and Without Coflex™ Interlaminar Technology Treating Lumbar Spinal Stenosis

N/A

CT Scan

Spinal Fractures

N/A

Clinical Trials (1)

NCT02918669Study to Investigate the Long Term Survivorship of Coflex

N/A

Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

Cancer

N/A

Clinical Trials (1)

NCT02749838Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

N/A

Pentosan Polysulfate Sodium twice weekly

Osteoarthritis, Knee

Phase 2/3

Clinical Trials (1)

NCT04809376Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Phase 2/3

Pentosan Polysulfate Sodium twice weekly

Osteoarthritis, Knee

Phase 3

Clinical Trials (1)

NCT06917404A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

Phase 3

SD-101 Dermal Cream

Epidermolysis Bullosa (EB)

Phase 3

Clinical Trials (1)

NCT07482813An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Phase 3

SD-101 Dermal Cream

Epidermolysis Bullosa (EB)

Phase 3

Clinical Trials (1)

NCT07482787Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa